Literature DB >> 18601949

The cyclic AMP phenotype of fragile X and autism.

Daniel J Kelley1, Anita Bhattacharyya, Garet P Lahvis, Jerry C P Yin, Jim Malter, Richard J Davidson.   

Abstract

Cyclic AMP (cAMP) is a second messenger involved in many processes including mnemonic processing and anxiety. Memory deficits and anxiety are noted in the phenotype of fragile X (FX), the most common heritable cause of mental retardation and autism. Here we review reported observations of altered cAMP cascade function in FX and autism. Cyclic AMP is a potentially useful biochemical marker to distinguish autism comorbid with FX from autism per se and the cAMP cascade may be a viable therapeutic target for both FX and autism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18601949      PMCID: PMC2642647          DOI: 10.1016/j.neubiorev.2008.06.005

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  202 in total

Review 1.  PDE4 cAMP-specific phosphodiesterases.

Authors:  M D Houslay
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001

2.  Eph receptors tingle the spine.

Authors:  M Henkemeyer; J Frisén
Journal:  Neuron       Date:  2001-09-27       Impact factor: 17.173

3.  Short-term regulation of PDE4 activity.

Authors:  V Manganiello
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

Review 4.  Anxiety and affective style: role of prefrontal cortex and amygdala.

Authors:  Richard J Davidson
Journal:  Biol Psychiatry       Date:  2002-01-01       Impact factor: 13.382

5.  Assessing the emetic potential of PDE4 inhibitors in rats.

Authors:  A Robichaud; C Savoie; P B Stamatiou; N Lachance; P Jolicoeur; R Rasori; C C Chan
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

6.  Instability of a (CGG)98 repeat in the Fmr1 promoter.

Authors:  C J Bontekoe; C E Bakker; I M Nieuwenhuizen; H van der Linde; H Lans; D de Lange; M C Hirst; B A Oostra
Journal:  Hum Mol Genet       Date:  2001-08-01       Impact factor: 6.150

7.  Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency.

Authors:  Jianxue Li; Marc R Pelletier; Jose-Luis Perez Velazquez; Peter L Carlen
Journal:  Mol Cell Neurosci       Date:  2002-02       Impact factor: 4.314

8.  EphB/syndecan-2 signaling in dendritic spine morphogenesis.

Authors:  I M Ethell; F Irie; M S Kalo; J R Couchman; E B Pasquale; Y Yamaguchi
Journal:  Neuron       Date:  2001-09-27       Impact factor: 17.173

9.  Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).

Authors:  Simon J MacKenzie; George S Baillie; Ian McPhee; Carolynn MacKenzie; Rachael Seamons; Theresa McSorley; Jenni Millen; Matthew B Beard; Gino van Heeke; Miles D Houslay
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

10.  Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein.

Authors:  Shin Nakagawa; Ji-Eun Kim; Rena Lee; Jessica E Malberg; Jingshan Chen; Cathy Steffen; Ya-Jun Zhang; Eric J Nestler; Ronald S Duman
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

View more
  20 in total

1.  Interference of the complex between NCS-1 and Ric8a with phenothiazines regulates synaptic function and is an approach for fragile X syndrome.

Authors:  Alicia Mansilla; Antonio Chaves-Sanjuan; Nuria E Campillo; Ourania Semelidou; Loreto Martínez-González; Lourdes Infantes; Juana María González-Rubio; Carmen Gil; Santiago Conde; Efthimios M C Skoulakis; Alberto Ferrús; Ana Martínez; María José Sánchez-Barrena
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-24       Impact factor: 11.205

2.  Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders.

Authors:  Jessica A Kaczorowski; Taylor F Smith; Amanda M Shrewsbury; Leah R Thomas; Valerie S Knopik; Maria T Acosta
Journal:  Behav Genet       Date:  2020-02-05       Impact factor: 2.805

3.  (S)-5-(2'-Fluorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine, a Serotonin Receptor Modulator, Possesses Anticonvulsant, Prosocial, and Anxiolytic-like Properties in an Fmr1 Knockout Mouse Model of Fragile X Syndrome and Autism Spectrum Disorder.

Authors:  Jessica L Armstrong; Austen B Casey; Tanishka S Saraf; Munmun Mukherjee; Raymond G Booth; Clinton E Canal
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-21

Review 4.  Epac2-mediated dendritic spine remodeling: implications for disease.

Authors:  Peter Penzes; Kevin M Woolfrey; Deepak P Srivastava
Journal:  Mol Cell Neurosci       Date:  2010-11-27       Impact factor: 4.314

Review 5.  Drosophila modeling of heritable neurodevelopmental disorders.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Curr Opin Neurobiol       Date:  2011-05-17       Impact factor: 6.627

Review 6.  Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back.

Authors:  Christina Gross; Anne Hoffmann; Gary J Bassell; Elizabeth M Berry-Kravis
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

7.  Fragile X mental retardation protein regulates heterosynaptic plasticity in the hippocampus.

Authors:  Steven A Connor; Charles A Hoeffer; Eric Klann; Peter V Nguyen
Journal:  Learn Mem       Date:  2011-03-23       Impact factor: 2.460

8.  Social, communication, and cortical structural impairments in Epac2-deficient mice.

Authors:  Deepak P Srivastava; Kelly A Jones; Kevin M Woolfrey; Jeffrey Burgdorf; Theron A Russell; Abigail Kalmbach; Hyerin Lee; Connie Yang; Mazdak M Bradberry; David Wokosin; Joseph R Moskal; Manuel F Casanova; Jack Waters; Peter Penzes
Journal:  J Neurosci       Date:  2012-08-22       Impact factor: 6.167

9.  PDE11A regulates social behaviors and is a key mechanism by which social experience sculpts the brain.

Authors:  Shweta Hegde; Hao Ji; David Oliver; Neema S Patel; Nicolas Poupore; Michael Shtutman; Michy P Kelly
Journal:  Neuroscience       Date:  2016-08-17       Impact factor: 3.590

Review 10.  Autism overflows: increasing prevalence and proliferating theories.

Authors:  Lynn Waterhouse
Journal:  Neuropsychol Rev       Date:  2008-11-18       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.